How RWE can help Biotechs optimize the value of their asset
Traditionally, real-world data (RWD) and real-world evidence (RWE) have not been viewed as critical components to be incorporated into the drug development journey to demonstrate value for market access and product launch/commercialization. With the majority of small and emerging biotech companies choosing to seek out partnership or licensing deals to support pivotal trials and ultimately commercialization of their asset, there was little exposure to the numerous benefits RWD and RWE can provide to these companies early in their development planning and execution.
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Guide for Real-World Evidence
May 21, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Podcast
Leveraging people, processes and technology to deliver for biotech
Oct 1, 2024
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021